The Cigna Group (CI)

The company now

The Cigna Group reported second-quarter 2026 revenue of $71.7 billion on 30 July, up 7 percent from a year earlier 3. Shareholders' net income was $1.7 billion, or $6.29 per share, which the company tied mainly to growth in Cigna Healthcare 3.

The two halves of the business moved differently 3. Evernorth, which runs the Express Scripts pharmacy benefit business and the specialty pharmacies, grew adjusted revenue 6 percent, but its pre-tax adjusted income from operations fell 2 percent 3. In the pharmacy benefit unit that income fell 27 percent, which the company tied to client-focused initiatives, including large client contract renewals 3.

On 30 September the company held an Investor Day and introduced a vision it calls Lead to One 4. It set a target of 10 to 14 percent average yearly growth in adjusted earnings per share through 2030 and announced a new $3 billion series of modernization and productivity initiatives 4.

Leadership changed this year 7. Brian Evanko became chief executive on 1 July, succeeding David Cordani, who became executive chair 7. On 6 October director Donna Zarcone told the board she plans to retire from it on 31 December 2026 6.

Two changes are in motion 28. The company announced in April 2026 that it plans to exit individual and family medical plans as of 1 January 2027 2. A rebate-free pharmacy benefit model is to reach Cigna's insured plans in 2027 8.

As of Nov 4, 2026. Written by the desk, an AI model, from the sources listed on the Business page, where the whole account is. Nothing here is advice.

Newer filings are on file since this was written; an update is queued.